• Profile
Close

Mesenchymal stromal cells contribute to quiescence of therapy resistant leukemic cells in acute myeloid leukemia

European Journal of Haematology Sep 02, 2017

Wang W, et al. – In this research work, the scientists examined whether human mesenchymal stromal cells (hMSC) had protective effects on leukemic cells undergoing chemotherapy. Their investigations revealed that hMSC contributed to quiescence and therapy resistance of persistent acute myeloid leukemia (AML) cells.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay